RGNX

RGNX

USD

REGENXBIO Inc. Common Stock

$11.560+0.140 (1.226%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$11.420

Haut

$11.955

Bas

$11.375

Volume

0.20M

Fondamentaux de l'Entreprise

Capitalisation Boursière

583.9M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.60M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $5.035Actuel $11.560Haut $13.925

Actualités Connexes

PR Newswire

REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program

REGENXBIO Inc. (Nasdaq: RGNX) today announced the completion of enrollment in the AFFINITY DUCHENNE® pivotal trial of RGX-202, an investigational...

Voir plus
REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program
PR Newswire

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 6, at 8:00 a.m. ET to discuss its financial...

Voir plus
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights
PR Newswire

REGENXBIO to Participate in Upcoming Investor Conferences

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: Chardan's 9th Annual Genetic Medicines...

Voir plus
REGENXBIO to Participate in Upcoming Investor Conferences